Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis.
about
Drugs and oral disorders.Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.Streptococcus salivarius bacteremia and spontaneous bacterial peritonitis in liver transplantation candidates.Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis.Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
P2860
Q33592359-F2D18EBE-F890-4AAA-BAB6-FD5D645FCE23Q33952985-D737E91E-47FD-4F26-A458-A05A6F0129A1Q33960926-0AD9796F-1B71-4361-AC50-30897B67B627Q34584342-78FA62E6-B450-441E-A68A-345645528D6FQ35597437-7AD84EC2-0F9D-4E00-9408-FFC0B5687335Q35629733-E2A51E47-B232-496D-A1CE-9FD307EF57A8Q37598714-7B178823-8C0E-4B42-A109-CFFA32F890EFQ40502316-D330084F-8399-4966-A412-D6AFCAA6D723Q44417864-DEA3F30D-3512-4793-A2C1-F2D592B3820DQ45184235-4A194952-E836-4F13-8531-7688E2AE3308
P2860
Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Bacteremia due to oral viridan ...... han antibacterial prophylaxis.
@en
Bacteremia due to oral viridan ...... han antibacterial prophylaxis.
@nl
type
label
Bacteremia due to oral viridan ...... han antibacterial prophylaxis.
@en
Bacteremia due to oral viridan ...... han antibacterial prophylaxis.
@nl
prefLabel
Bacteremia due to oral viridan ...... han antibacterial prophylaxis.
@en
Bacteremia due to oral viridan ...... han antibacterial prophylaxis.
@nl
P2093
P356
P1476
Bacteremia due to oral viridan ...... han antibacterial prophylaxis.
@en
P2093
Dompeling EC
Donnelly JP
de Pauw BE
P304
P356
10.1093/CLINIDS/20.2.469
P407
P577
1995-02-01T00:00:00Z